Clin2
NCT07094373Possibly a fitRecruiting

Validating chlamydia diagnosis codes in health records

Chlamydial Infections

Part of Infections clinical trials.

This study checks how well chlamydia diagnosis codes in electronic health records match lab test results. It may help people who have been diagnosed with or tested for chlamydia.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
533,000 people
Ages
14 years to 44 years
Study type
Observational

Who can take part

  • You have a medical record showing either a chlamydia diagnosis code or a lab test for chlamydia
  • You had at least one doctor visit within 30 days before and after that diagnosis or test
  • If you only have a diagnosis and no lab test, you may not be included in the main analysis

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07596316Recruiting
Understanding Immune Response to Chlamydia Infection

This study examines how your body's immune system responds to a Chlamydia trachomatis infection by analyzing urine and blood samples. Researchers hope to better understand infection patterns and improve future treatments.

Antwerp, Antwerp
NCT07399873Not yet recruiting
Comparing Fast STI Testing in a Sexual Health Clinic

This trial compares two ways of testing for chlamydia and gonorrhea in people who don't have symptoms. It aims to see if faster, point-of-care testing improves outcomes compared to standard lab testing.

NCT07679789Not yet recruiting
Pneumonia caused by Chlamydia pneumoniae bacteria

This study looks at patients who had pneumonia caused by a specific bacteria called Chlamydia pneumoniae. It aims to learn more about this type of pneumonia to help improve diagnosis and treatment.

Saint-Denis
NCT06891417Recruiting· Phase 1/Phase 2
Chlamydia mRNA vaccine study for adults 18-29

This study tests a new mRNA vaccine designed to prevent chlamydia infection. It is for adults aged 18 to 29 who have a higher risk of getting chlamydia.

Bruce, Australian Capital Territory
NCT06428643Recruiting
Chlamydia Testing and Treatment for Young African Americans

This study tests a program to find and treat chlamydia in young African American people in New Orleans. If you qualify, you may get free testing and treatment to help stop the spread of infection.

New Orleans, Louisiana
NCT05897034Not yet recruiting· Phase 2/Phase 3
Study antibiotics for untreated gonorrhea and chlamydia

This trial tests a combination of medications (doxycycline, pentoxifylline, and nitazoxanide) in men with untreated gonorrhea and chlamydia. It may help clear the infection more effectively, but you must meet specific safety and health criteria.

Hear when a new Chlamydial Infections trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.